Chen-Yuan Lin, M.D., Ph.D., is a physician in the Hematology and Oncology Department at China Medical University Hospital. He specializes in treating various cancers, particularly esophageal cancer, and leads multiple clinical trials. He is responsible for teaching and mentoring physicians and pharmacists, with a research focus on the tumor immune microenvironment and personalized tumor antigens. Leveraging his experience with high-dose interleukin-2 and immune checkpoint inhibitors, Dr. Lin is dedicated to enhancing the precision of immunotherapy and developing more effective cancer treatment strategies.targeting cancer cells and ultimately achieving more precise treatment outcomes.

Lung cancer Pleural disease Chest ultrasound Cough

Lung cancer, include diagnosis, target therapy, immunotherapy, chemotherapy Chest image interpretation Chronic Obstructive Pulmonary Disease, Bronchial asthma, Pulmonary fibrosis

Interventional bronchoscopy Lung cancer Chronic Obstructive Pulmonary Disease Asthma

HBO, lung cancer, critical care, airway disease, general pulmonary medicine

Acute hepatitis
Chronic hepatitis B and C

Digestive sonography and intervention therapy Gastrointestinal endoscopy and intervention therapy Hepatitis and liver tumor intervention therapy

Liver fibrosis and cirrhosis
Liver cancer
Viral hepatitis
Hepatobiliary/ pancreatic/ gastrointestinal diseases
Ultrasound-guided diagnosis and interventions
Esophagogastroduodenoscopy and colonoscopy

Doctor Jiunn-Horng Chen specializes in arthritis and allergy, including: immunological disease ( systemic lupus erythematosus, xerosis, Dermatomyositis, scleroderma), various arthritis (Rheumatoid arthritis, spondylitis ankylosans, gout, degenerative arthritis, fibromyalgia, osteoporosis as well as hives, asthma and allergy. Doctor Chen was a research fellow of the Department of Internal Medicine at UBC and is the Vice-President of the British Columbia Chinese Medicine Acupuncture Alliance. In the recent years, Doctor Chen has presented papers regarding arthritis, fibromyalgia and rheumatoid diseases in foreign rheumatoid journals; including: Arthritis & Rheumatology, Annals of the Rheumatic Diseases, Journal of Rheumatology etc. Thus he participated in forming the 2015 World Gout Diagnosis Guidelines, 2013 Taiwan Gout Introduction and joined Taiwan’s Fibromyalgia Consultation Committee to promote health education regarding fibromyalgia.

Dr. Rong-Hsing Chen serves as Director of Division of Metabolism at China Medical University Hospital. His clinical and research interests are: therapy of diabetes mellitus and pituitary disease and single neucleotide polymorphism of gene in autoimmune thyroid disease.